• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Helix BioPharma Corp

+ Add to Watchlist


1.159 EUR 0.016 1.40%

As of 02:17:16 ET on 12/19/2014.

Snapshot for Helix BioPharma Corp (HBP)

Open: 1.100 Day's Range: 1.100 - 1.189 Volume: 0
Previous Close: 1.143 52wk Range: 0.830 - 1.540 1-Yr Rtn: +25.70%

Stock Chart for HBP

No chart data available.
  • HBP:GR 1.159
  • 1D
  • 1M
  • 1Y
Interactive HBP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HBP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 87.97
Shares Outstanding (M) 75.90
30 Day Average Volume 127
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HBP

No data available

Company Profile & Key Executives for HBP

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is developing products for the prevention and treatment of cancer based on its proprietary technologies.

Robert A VerhagenPresident/CEOPhotios Michalargias "Frank"CFO/Secretary
Heman ChaoChief Scientific Officer
More Company Profile & Key Executives for HBP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil